Schedule of Net Sales and Operating Profit by Segment |
The Company’s net sales, significant segment expenses and operating profit, by reportable segment were: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | Net sales | | Cost of Sales | | Selling, general and administrative expenses | | Other (income) expense, net (1) | | Operating Profit | Reportable Segments | | | | | | | | | | Oral, Personal and Home Care | | | | | | | | | | North America | $ | 1,027 | | | $ | 403 | | | $ | 417 | | | $ | 13 | | | $ | 194 | | Latin America | 1,207 | | | 527 | | | 318 | | | (6) | | | 367 | | Europe | 738 | | | 275 | | | 272 | | | 7 | | | 184 | | Asia Pacific | 687 | | | 265 | | | 242 | | | (7) | | | 187 | | Africa/Eurasia | 295 | | | 117 | | | 110 | | | 3 | | | 65 | | Total Oral, Personal and Home Care | 3,954 | | | | | | | | | 997 | | Pet Nutrition | 1,157 | | | 462 | | | 430 | | | — | | | 264 | | Reconciliation with Total Company Operating Profit | | | | | | | | | | Corporate | | | | | | | | | (181) | | Total | $ | 5,110 | | | | | | | | | $ | 1,080 | |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2025 | | Net sales | | Cost of Sales | | Selling, general and administrative expenses | | Other (income) expense, net (1) | | Operating Profit | Reportable Segments | | | | | | | | | | Oral, Personal and Home Care | | | | | | | | | | North America | $ | 2,025 | | | $ | 780 | | | $ | 832 | | | $ | 23 | | | $ | 390 | | Latin America | 2,350 | | | 1,014 | | | 633 | | | (13) | | | 715 | | Europe | 1,427 | | | 532 | | | 526 | | | 14 | | | 356 | | Asia Pacific | 1,378 | | | 526 | | | 481 | | | (15) | | | 385 | | Africa/Eurasia | 566 | | | 221 | | | 216 | | | 7 | | | 122 | | Total Oral, Personal and Home Care | 7,746 | | | | | | | | | 1,968 | | Pet Nutrition | 2,275 | | | 899 | | | 852 | | | 1 | | | 523 | | Reconciliation with Total Company Operating Profit | | | | | | | | | | Corporate | | | | | | | | | (334) | | Total | $ | 10,021 | | | | | | | | | $ | 2,156 | |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2024 | | Net sales | | Cost of Sales | | Selling, general and administrative expenses | | Other (income) expense, net (1) | | Operating Profit | Reportable Segments | | | | | | | | | | Oral, Personal and Home Care | | | | | | | | | | North America | $ | 1,037 | | | $ | 396 | | | $ | 426 | | | $ | 3 | | | $ | 213 | | Latin America | 1,267 | | | 504 | | | 353 | | | (6) | | | 417 | | Europe | 685 | | | 258 | | | 251 | | | 7 | | | 169 | | Asia Pacific | 682 | | | 260 | | | 232 | | | (6) | | | 195 | | Africa/Eurasia | 273 | | | 105 | | | 103 | | | 1 | | | 64 | | Total Oral, Personal and Home Care | 3,944 | | | | | | | | | 1,058 | | Pet Nutrition | 1,114 | | | 459 | | | 420 | | | 1 | | | 235 | | Reconciliation with Total Company Operating Profit | | | | | | | | | | Corporate | | | | | | | | | (201) | | Total | $ | 5,058 | | | | | | | | | $ | 1,092 | |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2024 | | Net sales | | Cost of Sales | | Selling, general and administrative expenses | | Other (income) expense, net (1) | | Operating Profit | Reportable Segments | | | | | | | | | | Oral, Personal and Home Care | | | | | | | | | | North America | $ | 2,073 | | | $ | 786 | | | $ | 845 | | | $ | 15 | | | $ | 427 | | Latin America | 2,520 | | | 1,005 | | | 698 | | | (5) | | | 822 | | Europe | 1,358 | | | 525 | | | 497 | | | 15 | | | 321 | | Asia Pacific | 1,408 | | | 544 | | | 474 | | | (13) | | | 402 | | Africa/Eurasia | 549 | | | 211 | | | 202 | | | 6 | | | 130 | | Total Oral, Personal and Home Care | 7,908 | | | | | | | | | 2,102 | | Pet Nutrition | 2,216 | | | 941 | | | 833 | | | 10 | | | 433 | | Reconciliation with Total Company Operating Profit | | | | | | | | | | Corporate | | | | | | | | | (397) | | Total | $ | 10,124 | | | | | | | | | $ | 2,139 | |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 30, | | June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Net sales | | | | | | | | Oral Care | 43 | % | | 42 | % | | 44 | % | | 43 | % | Personal Care | 18 | % | | 19 | % | | 17 | % | | 18 | % | Home Care | 16 | % | | 17 | % | | 16 | % | | 17 | % | Pet Nutrition | 23 | % | | 22 | % | | 23 | % | | 22 | % | Total Net sales | 100 | % | | 100 | % | | 100 | % | | 100 | % |
Capital expenditures and depreciation and amortization expense by segment were: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | June 30, | | June 30, | | | | 2025 | | 2024 | | 2025 | | 2024 | | | | | Capital expenditures | | | | | | | | | | | | Oral, Personal and Home Care | | | | | | | | | | | | North America | $ | 14 | | | $ | 13 | | | $ | 30 | | | $ | 21 | | | | | | Latin America | 21 | | | 25 | | | 50 | | | 46 | | | | | | Europe | 12 | | | 13 | | | 20 | | | 20 | | | | | | Asia Pacific | 19 | | | 10 | | | 32 | | | 19 | | | | | | Africa/Eurasia | 2 | | | 1 | | | 4 | | | 3 | | | | | | Total Oral, Personal and Home Care | 68 | | | 62 | | | 136 | | | 109 | | | | | | Pet Nutrition | 22 | | | 31 | | | 43 | | | 84 | | | | | | Corporate | 18 | | | 24 | | | 53 | | | 50 | | | | | | Total Capital expenditures | $ | 108 | | | $ | 117 | | | $ | 232 | | | $ | 243 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | June 30, | | June 30, | | | | 2025 | | 2024 | | 2025 | | 2024 | | | | | Depreciation and amortization | | | | | | | | | | | | Oral, Personal and Home Care | | | | | | | | | | | | North America | $ | 30 | | | $ | 32 | | | $ | 60 | | | $ | 63 | | | | | | Latin America | 27 | | | 26 | | | 51 | | | 53 | | | | | | Europe | 16 | | | 16 | | | 32 | | | 32 | | | | | | Asia Pacific | 20 | | | 20 | | | 40 | | | 40 | | | | | | Africa/Eurasia | 2 | | | 2 | | | 4 | | | 4 | | | | | | Total Oral, Personal and Home Care | 95 | | | 96 | | | 187 | | | 192 | | | | | | Pet Nutrition | 31 | | | 37 | | | 63 | | | 67 | | | | | | Corporate | 25 | | | 24 | | | 49 | | | 48 | | | | | | Total Depreciation and amortization | $ | 151 | | | $ | 157 | | | $ | 299 | | | $ | 307 | | | | | |
|